Prescription Drug Competition Act of 2000

Summary

Prescription Drug Competition Act of 2000 - Requires a brand name drug company and a generic drug applicant that enter into an agreement regarding the sale or manufacture of a generic drug determined or likely to be the therapeutic equivalent of such brand name drug, when such agreement could limit the research, development, manufacture, marketing, or sale of such generic drug, to file with the Federal Trade Commission and the Secretary of Health and Human Services the text of such agreement and an explanation of whether such agreement could delay, restrain, limit, or otherwise interfere with the production, manufacture, or sale of the generic drug in question. Requires such filing within ten days of agreement execution. Provides civil penalties for violation.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 20 September 2000

   Introduced

   Referred to the Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 20 September 2000

   Introduced

   Referred to the Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

3. 20 September 2000

   Introduced

   Sponsor introductory remarks on measure. (CR E1538)

   Source: IntroReferral

4. 20 September 2000

   Introduced

   Introduced in House

   Source: IntroReferral

5. 20 September 2000

   Introduced

   Introduced in House

   Source: IntroReferral

6. 20 October 2000

   Referred

   Referred to the Subcommittee on Health and Environment.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 20 September 2000 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 20 September 2000

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 20 September 2000

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 20 September 2000

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Waxman, Henry A. [D-CA-33] · D · Sponsor
• Rep. Stark, Fortney Pete [D-CA-13] · D · Sponsor
• Sen. Brown, Sherrod [D-OH] · D · Sponsor
• Rep. Berry, Marion [D-AR-1] · D · Sponsor
• Sen. Coburn, Tom [R-OK] · R · Sponsor
• Rep. Deutsch, Peter [D-FL-20] · D · Sponsor
• · hsif00 · Standing
• · hsju00 · Standing

Related records

No cross-record relationships stored yet.